SK Bioscience, L House Vision Declaration Ceremony..."Leap to Global Bio Hub"

SK Bioscience announced on the 12th that it held a vision declaration ceremony at its vaccine production plant, Andong L House.

원본보기 아이콘

On the 11th, SK Bioscience held the L House vision declaration ceremony at L House, attended by approximately 450 executives and L House members, including Jaeyong Ahn, President of SK Bioscience, Hoon Kim, Global R&BD Head, and Sangkyun Lee, L House Plant Manager (Vice President). The vision declaration ceremony was designed to review the achievements and key milestones L House reached during the COVID-19 pandemic and to share future strategies and goals at the turning point toward the endemic era.

At this event, SK Bioscience shared the 'SKBS 3.0' future strategy and digital establishment plan, consisting of concrete action tasks and implementation methods to grow as a global company in the endemic era. In particular, SK Bioscience selected obtaining the U.S. Food and Drug Administration (FDA) cGMP (Current Good Manufacturing Practice) certification as a core task for L House to execute its future strategy and achieve its vision, pledging to secure world-class production capabilities through this.

Jaeyong Ahn, President of SK Bioscience, emphasized, "Today's vision declaration ceremony is a place where L House members unite their strength through a One Team culture to declare their determination to achieve One Goal." He added, "We will strive to become a global vaccine and bio-specialized company that contributes to improving human health by securing a diverse vaccine portfolio and promoting sustainable growth so that the sweat and efforts of our members do not go in vain."

Established in 2012 in Andong, Gyeongbuk, L House possesses foundational technologies and production facilities for vaccine manufacturing, including cell culture, bacterial culture, genetic recombination, and protein conjugate vaccines, enabling the production of next-generation vaccines such as cell culture vaccines. SK Bioscience plans to expand facilities at L House by approximately 30,000 pyeong and build a global top-tier research and development (R&D) network through the Global R&PD Center under construction in Songdo, Incheon, with an investment of 325.7 billion KRW, scheduled for completion in 2025.

The vision declaration ceremony held by SK Bioscience on the 11th at the Andong L-House vaccine production plant.
[Photo by SK Bioscience]

원본보기 아이콘

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.